BusinessTESARO Announces Collaboration to Evaluate Combination of ZEJULA® (Niraparib) and Anti-PD-L1 Cancer Immunotherapy in Metastatic Bladder CancerBy Nasdaq OMXFeb 26, 2018, 8:00 PM UTC
BusinessAurora Advanced Flow Cytometry System from Cytek Biosciences Continues to Gain TractionBy Nasdaq OMXFeb 22, 2018, 3:00 PM UTC
BusinessEnhanced MuScreen™ Platform Revolutionizes Preclinical Development of ImmunotherapeuticsBy Nasdaq OMXFeb 9, 2018, 1:00 PM UTC
BusinessTreos Bio Announces FDA Approval of IND of Its First PolyPEPI™ Precision Cancer Vaccine for Metastatic Colorectal CancerBy Nasdaq OMXJan 24, 2018, 1:15 PM UTC
BusinessData on Novel Humanized Models for Targeted Immunotherapy Development, a CrownBio Conference Talk on January 24th, 2018By Nasdaq OMXJan 23, 2018, 1:40 PM UTC
BusinessInnovative Humanized Research Strategies for Immuno-Oncology Drug Development, Crown Bioscience Hosts a Live WebinarBy Nasdaq OMXJan 17, 2018, 1:01 PM UTC
BusinessVBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901By Nasdaq OMXJan 17, 2018, 1:00 PM UTC
